ArticleActa neurologica Belgica2026
Association between cerebrospinal fluid LRRK2 and incident orthostatic hypotension differs by genetic background in Parkinson's disease.
Article in Acta neurologica Belgica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOrthostatic hypotension (OH) is an important manifestation of cardiovascular autonomic dysfunction in Parkinson's disease (PD), but biomarkers associated with incident OH have not been well established. Cerebrospinal fluid (CSF) LRRK2 provides a measurable marker of LRRK2-related biology, but its association with incident OH is unknown.
objectiveTo determine whether baseline CSF LRRK2 is associated with incident OH and whether this association differs between sporadic PD and LRRK2-PD.
methodsWe analyzed longitudinal Parkinson's Progression Markers Initiative (PPMI) data from 190 participants with PD, including 159 participants free of OH at baseline with follow-up orthostatic assessments. Cox proportional hazards models evaluated the association between standardized ln-transformed baseline CSF LRRK2 and time to incident OH, including a CSF LRRK2-by-genetic-group interaction and adjustment for age, sex, disease duration, and baseline systolic blood pressure change after standing.
resultsDuring follow-up, 52 of 159 participants developed OH. Higher baseline CSF LRRK2 was associated with a higher hazard of incident OH in sporadic PD (HR 10.50 per 1-SD higher ln-transformed CSF LRRK2, 95% CI 2.95-37.35; p < 0.001), whereas no clear association was observed in LRRK2-PD (HR 1.74, 95% CI 0.63-4.79; p = 0.284). The CSF LRRK2-by-genetic-group interaction was significant (interaction HR 0.166, 95% CI 0.083-0.331; p < 0.001) and remained consistent across sensitivity analyses.
conclusionsThe association between baseline CSF LRRK2 and incident OH differed by genetic background. Baseline CSF LRRK2 was associated with incident OH in sporadic PD, whereas no clear association was observed in LRRK2-PD. Independent replication is required.
Indexed as
Identifiers
42734894What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.